Explore rPeptide's Aβ for your research needs!
Beta-Amyloid (1-42) (cat# A-1002): t.ly/SWqy_
Beta-Amyloid (1-42), Starter Kit (cat# A-1160): t.ly/GUrv6
#BetaAmyloid #Alzheimers #Neurodegeneration #rPeptide #AmyloidResearch
rPeptide's new ABT Fibril Complex consists of Tau-441, Beta-Amyloid 1-42, and Alpha-Synuclein together in one validated system. Built for the complexity of real Alzheimer's pathology. 🔬
ABT Fibril Complex: t.ly/g4Jpk
#rPeptide #PFFs #Alzheimers #Neurodegeneration #Tau #AlphaSynuclein #BetaAmyloid
Check out rPeptide's Beta-Amyloid 1-42 HFIP (Cat # A-1163) t.ly/KAT-q
For a quote, please reach out to Sales@rPeptide.com today!
#Amyloid #BA #HFIP #BetaAmyloid #Peptide #AlzheimersResearch #rPeptide
@rpeptide.bsky.social #BetaAmyloid preformed fibrils are the perfect tool and model to assist scientists in the discovery of new treatments & #diagnostictools for #neurodegenerative diseases such as #Alzheimers disease
www.stratech.co.uk/our-partners...
#brainhealth #oligomers #biomarkers
Check out our N15-labeled Beta-Amyloid 1-42: www.rpeptide.com/product/n15-...
As well as our N15-labeled Beta-Amyloid 1-40: www.rpeptide.com/product/n15-...
#N15 #BetaAmyloid #AlzheimersResearch #Dementia #rPeptide
To study amyloid processing, researchers used rPeptide’s Aβ(1-40) NH₄OH (Cat # A-1157) for consistent, reproducible results.
t.ly/BU0JQ
#BetaAmyloid #NH4OH #rPeptide
Explore @rpeptide.bsky.social expert products for #Alzheimers and #Parkinsons disease research
including antibodies recombinant #proteins, #peptides, preformed #fibrils for #BetaAmyloid, #Tau, #Synuclein, #Calmodulin...
Learn More here: www.stratech.co.uk/our-partners...
#neuroscience #neurology
New research maps how #BetaAmyloid 1-40 aggregates over time, showing how factors like temperature shape fibril formation in Alzheimer’s disease.
#rPeptide Beta-Amyloid 1-40 (A-1001) was used to track aggregation kinetics and morphology.
t.ly/d4COq
#Neuroscience #Alzheimers #ProteinAggregation
Explore our recombinant #BetaAmyloid and #APP products to support your research: www.rpeptide.com/products/pep...
#rPeptide #RDStartsHere
Using #rPeptide's high-purity recombinant #BetaAmyloid 1-40 (cat# A-1153) and 1-42 (cat# A-1163) as the aggregation substrates in these experiments allowed the researchers to reliably monitor how MDK affects fibril formation.
t.ly/_ebGd
#AlzheimersResearch
#Midkine (MDK) may help slow amyloid buildup in #Alzheimers disease. New findings show MDK reduces aggregation of Aβ40 and Aβ42 into fibrils, while loss of MDK increased plaque formation and microglial activation in AD mouse models.
t.ly/T9XdJ
#Neuroscience #BetaAmyloid #RDStartsHere #rPeptide
The results show how dependable reagents like rPeptide’s Amyloid peptides help make biomarker testing more precise and reproducible, while also highlighting a promising new approach for detecting early signs of #Alzheimers through spinal fluid analysis.
t.ly/dArAS
#BetaAmyloid #Research
A new study shows Khaya grandifoliola bark extracts can reduce βA 1-42 aggregation and target multiple disease pathways.
rPeptide’s #BetaAmyloid (1-42) was used to track fibrillation, highlighting plant-based promise in neurodegeneration research.
t.ly/nmxNM
#Neuroscience #Research #rPeptide
To study this mechanism, scientists used #rPeptide N15 Beta-Amyloid 1-42 (Cat# A-1102) to generate well-characterized Aβ oligomers for structural and biochemical analysis.
t.ly/4cC6l
#Research #Development #Neuroscience #BetaAmyloid
Using rPeptide’s synthetic Fluorescein Beta-Amyloid 1-42 (Cat# A-1119), researchers formed oligomeric Aβ species to model plaque-associated pathology in a mouse model.
t.ly/WHfm5
#BetaAmyloid #rPeptide
Aging #cats can naturally develop #dementia, displaying brain changes—such as #betaamyloid plaques that trigger inflammation and nerve damage—that closely mirror human #Alzheimer’s disease.
www.sciencenews.org/article/cat-...
To model neurodegeneration, our Beta-Amyloid 1–42 was used - it was found that select compounds could reduce BA induced cell damage. This work highlights how rPeptide’s tools enable researchers to screen new therapeutic compounds under disease-relevant conditions.
t.ly/tkZYw
#BetaAmyloid #BA42
A study shows that a chemical modification succinylation alters the behavior of #APP & #Tau linked to #Alzheimers. These changes promote toxic aggregation, contributing to plaque & tangle formation in the #brain.
The #researchers used our #BetaAmyloid 1–42 #AggregationKit t.ly/QtHwQ
t.ly/E6yTU
A @nature.com article reveals a link between #neurodegenerative proteins and #HIV. #Researchers found that #AlphaSynuclein and #BetaAmyloid fibrils enhance HIV-1 entry and replication in brain cells, offering new insight into HIV-associated neurocognitive disorders.
t.ly/t5fiq
#Recombinant
#Researchers explored the differential immune responses of aged versus young microglial cells. To investigate the role of Amyloid-Beta in these processes, they utilized rPeptide’s #BetaAmyloid 1-42 #AggregationKit to prepare and treat cells ahead of phagocytosis assays.
t.ly/2GGAM
BA: t.ly/qtpHs
This study explores how modulation of CD22 can alleviate Aβ induced neuroinflammation.
rPeptide’s #BetaAmyloid 1–42, HFIP was used to generate Aβ oligomers for in vitro and in vivo assays, as well as FITC Aβ 1–42 for #fluorescence based tracking.
t.ly/LWYf9
#HFIP: t.ly/N_t42
#FITC: t.ly/pGHDb
Explore @rpeptide.bsky.social expert products for #Alzheimers and #Parkinsons disease research
including antibodies recombinant #proteins, #peptides, preformed #fibrils for #BetaAmyloid, #Tau, #Synuclein,
#Calmodulin
🔗 www.stratech.co.uk/our-partners...